English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The actual increase in human longevity is possible due to the public health care and to the treatment of several chronic diseases, mainly in the oldest people. However, some of those drugs may have negative effects on the skeleton, not only decreasing bone mass, but also increasing the risk for fragility fractures. Osteoporosis is the most prevalent metabolic bone disease. It is characterized by a deterioration of bone microarchitecture and consequent fragility fractures. It is a heterogeneous and multifactorial etiological disease. About 20 to 30 % of osteoporotic postmenopausal women and more than 50 % men have a secondary induced etiology, namely the medications.

Тезисы III Международного симпозиума «Заболевания костей и суставов и возраст» (12-14 марта 2018, г. Львов, Украина)